SiftMed Eyes 4X growth in ARR this Year
Having recorded a $2.7 million funding round and 10X revenue growth in 2025, St. John’s-based SiftMed now hopes to book more sales – including enterprise clients – and capital in 2026.
In fact, Co-Founder and CEO Holly Hill revealed in an interview that the company’s ambition for this year is to increase its annual recurring revenue, or ARR, by four times. Assuming revenues and ARR are roughly